Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease

N Engl J Med. 2010 May 13;362(19):1846-8. doi: 10.1056/NEJMc1000094.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Adult
  • Cabergoline
  • Dopamine Agonists / therapeutic use*
  • Drug Therapy, Combination
  • Ergolines / therapeutic use*
  • Female
  • Humans
  • Hydrocortisone / urine
  • Ketoconazole / therapeutic use*
  • Male
  • Middle Aged
  • Pituitary ACTH Hypersecretion / drug therapy*
  • Pituitary ACTH Hypersecretion / urine
  • Prospective Studies
  • Receptors, Dopamine D2
  • Receptors, Somatostatin / antagonists & inhibitors
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use

Substances

  • Dopamine Agonists
  • Ergolines
  • Receptors, Dopamine D2
  • Receptors, Somatostatin
  • Somatostatin
  • somatostatin receptor 5
  • pasireotide
  • Cabergoline
  • Ketoconazole
  • Hydrocortisone